38241 Transplt autol hct/donor
Also known as: Autologous HCT, ASCT
Transplantation of autologous hematopoietic cells reinfused to the patient after high-dose chemotherapy or radiation.
In Plain Language
Transplanting patient's own cells; Cell reinfusion after chemotherapy
Clinical Context
Therapeutic reinfusion of previously harvested autologous cells for multiple myeloma, lymphoma, and other hematologic malignancies.
RVU Breakdown
| Work RVU | 2.93 |
| Total RVU | 2.93 |
Est. Medicare Payment
National estimate based on 2026 CMS PFS Conversion Factor ($33.40). Actual payment varies by locality (GPCI adjustment).
Billing & Documentation
As a surgical CPT code, proper documentation must include the operative report detailing the procedure performed, patient positioning, approach, findings, and any complications. Ensure the diagnosis code (ICD-10) supports medical necessity for the procedure.
How This Code Compares
With a work RVU of 2.93, this code ranks in the 20th percentile among Surgery codes — 2.7x below the median (8.00). The highest wRVU in this category is 106.19.
Specialties
Frequently Asked Questions
What is CPT code 38241?
CPT 38241 (Transplt autol hct/donor) is a Surgery code. Transplantation of autologous hematopoietic cells reinfused to the patient after high-dose chemotherapy or radiation.
What is the wRVU value for CPT 38241?
The work RVU for CPT 38241 is 2.93. This code is primarily used by Hematology/Oncology, Oncology Medicine.
When is CPT 38241 used?
Therapeutic reinfusion of previously harvested autologous cells for multiple myeloma, lymphoma, and other hematologic malignancies.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.